Join the discussion on the latest advancements, new norms, emerging trends and breakthrough topics from AACR by our expert panelists, offering clarity on the current landscape, with a deep dive into the latest advancements on how spatial biology is shaping precision medicine and cancer research. From advancements in immunotherapy to a new norm of precision medicine, navigating through the forefront of cancer research, influencing the trajectory of future treatments and patient care.

Hear expert perspectives on how the global research community has united in an unprecedented collaboration to tackle:

• The complexities of cancer across diverse populations and demographics.
• Integration of AI and its role in unraveling insights from medical and non-medical datasets, enabling earlier detection and understanding of various disease states.
• Keeping you informed about the latest developments in oncology, unravel insights from both medical and non-medical datasets, enabling earlier detection and understanding of various disease states.

Don't miss this opportunity to gain valuable insights from leading experts in the field.

Arutha Kulasinghe, PhD
Scientific Director of the Queensland
Spatial Biology Center in Brisbane,
Group Leader at The University of Queensland
View Biography

Suzanne Coberly, MD
Scientific Senior Director,
Discovery & Translational Pathology,
Oncogenesis TRC, Bristol Myers Squibb
View Biography

Doug Flora, MD
Executive Medical Director of Oncology Services
St. Elizabeth Healthcare
View Biography

Pascal Bamford, PhD
Senior Vice President,
R&D and Laboratory Operations
Akoya Biosciences
View Biography